Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3
- 30 April 2004
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 317 (2), 301-308
- https://doi.org/10.1016/j.bbrc.2004.03.026
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Obesity Wars: Molecular Progress Confronts an Expanding EpidemicCell, 2004
- Proopiomelanocortin-Derived Peptides in Rat Cerebrospinal Fluid and Hypothalamic Extracts: Evidence that Secretion Is Regulated with Respect to Energy BalanceEndocrinology, 2003
- Cellular Warriors at the Battle of the BulgeScience, 2003
- Neuropeptides and appetite controlDiabetic Medicine, 2002
- Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese miceProceedings of the National Academy of Sciences of the United States of America, 2002
- Fat in all the wrong placesNature, 2002
- Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptidesProceedings of the National Academy of Sciences of the United States of America, 2001
- Obesity and the Regulation of Energy BalanceCell, 2001
- Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase InhibitorsScience, 2000
- Central nervous system control of food intakeNature, 2000